BioAge Labs

Filed a patent for "combination therapy of apelin receptor modulators glp-1 agonists or analogs thereof for treating a disease or condition associated with weight gain" on Tue, January 3, 2023

Filed a patent for "combination therapy of apelin receptor modulators glp-1 agonists or analogs thereof for treating a disease or condition associated with weight gain" on Mon, July 17, 2023

Filed a patent for "combination therapy of apelin receptor modulators glp-1 agonists or analogs thereof for treating a disease or condition associated with weight gain" on Thu, August 3, 2023

Filed a patent for "combination therapy of apelin receptor modulators glp-1 agonists or analogs thereof for treating a disease or condition associated with weight gain" on Thu, August 17, 2023

Filed a patent for "combination therapy of apelin receptor modulator and glp-1 receptor agonist for treating a disease or condition associated with weight gain" on Mon, August 21, 2023

Filed a patent for "combination therapy of apelin receptor modulator and glp-1 receptor agonist for treating a disease or condition associated with weight gain" on Fri, September 1, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Wed, October 5, 2022

Filed a patent for "apelin receptor modulators for reducing bbb permeability" on Wed, October 5, 2022

Filed a patent for "n-oxide inhibitors of nlrp3 inflammasome" on Mon, November 14, 2022

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Mon, November 28, 2022

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Fri, December 2, 2022

Filed a patent for "rage fusion proteins with improved stability and ligand binding affinity and uses thereof" on Thu, July 6, 2023

Filed a patent for "apelin receptor modulators for reducing bbb permeability and treatment of neurodegenerative diseases" on Tue, January 3, 2023

Filed a patent for "apelin receptor modulators for reducing bbb permeability and treatment of neurodegenerative diseases" on Tue, January 3, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Tue, January 3, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Tue, January 3, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Wed, January 4, 2023

Filed a patent for "n-oxide inhibitors of nlrp3 inflammasome" on Thu, August 3, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Mon, March 13, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Mon, April 3, 2023

Filed a patent for "survival prediction using metabolomic profiles" on Thu, March 28, 2024

Filed a patent for "apelin receptor modulators for treatment of a disorder or disease associated with bbb permeability" on Thu, February 8, 2024

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Mon, July 10, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Thu, August 3, 2023

Filed a patent for "apelin receptor modulators for treating age-related muscle conditions" on Thu, August 17, 2023